Pharma BD Deal Intelligence
Cephalon, Inc. / Salmedix, Inc.
2005 · Acquisition/Merger · $160M · Complete
Announcement Sentiment
83
Strongly positive
Cephalon agrees to acquire Salmedix for $160M cash. Gains bendamustine (later Treanda) - became >$1B oncology blockbuster.
Key facts
- Announced May 13, 2005
- Closed Jun 14, 2005
- Deal value $160M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals